JPS5844210B2 - Highly sensitive and simple colorimetric determination method for acetoacetic acid in blood - Google Patents

Highly sensitive and simple colorimetric determination method for acetoacetic acid in blood

Info

Publication number
JPS5844210B2
JPS5844210B2 JP8680378A JP8680378A JPS5844210B2 JP S5844210 B2 JPS5844210 B2 JP S5844210B2 JP 8680378 A JP8680378 A JP 8680378A JP 8680378 A JP8680378 A JP 8680378A JP S5844210 B2 JPS5844210 B2 JP S5844210B2
Authority
JP
Japan
Prior art keywords
absorbance
acetoacetic acid
solution
blood
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8680378A
Other languages
Japanese (ja)
Other versions
JPS5515004A (en
Inventor
優 原納
幸男 繁田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Priority to JP8680378A priority Critical patent/JPS5844210B2/en
Publication of JPS5515004A publication Critical patent/JPS5515004A/en
Publication of JPS5844210B2 publication Critical patent/JPS5844210B2/en
Expired legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明は血中ケトン体、殊に血清中のアセト酢酸の簡易
分別定量法に係る。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a simple method for the differential determination of blood ketone bodies, particularly acetoacetic acid in serum.

糖尿病患者の臨床診断に際して血清中のケトン体量を測
定することが極めて重要であることは従来より知られて
いる。
It has been known for a long time that it is extremely important to measure the amount of ketone bodies in serum when clinically diagnosing diabetic patients.

しかしながら、この目的に於て現在一般に使用されてい
るのはニトロプルジッド法と酵素法とであるが、前者は
半定量法であって不正確であり、後者はその操作手段が
極めて煩雑であると謂う欠陥を有している。
However, the nitropurgide method and the enzyme method are currently commonly used for this purpose, but the former is a semi-quantitative method and is inaccurate, and the latter requires extremely complicated operating procedures. It has a defect called.

斯くて本発明の基本的目的は、感度及び正確度に優れた
ジアゾニウム塩とのカップリング反応を利用して血清中
のアセト酢酸を比色定量する方法を提供することにある
Therefore, the basic object of the present invention is to provide a method for colorimetrically determining acetoacetic acid in serum using a coupling reaction with a diazonium salt that has excellent sensitivity and accuracy.

この目的に供し得るものとして従来知られているジアゾ
ニウム塩としては2.5−ジクロロベンゼンジアゾニウ
ムクロライドが存するがこれは液状であり且つ不安定で
あるので血清中のアセト酢酸測定の当日に新たに調製し
なければならないと謂う煩られしさがあり、しかも発色
生成物が不安定であるので測定値がバラツクと言う欠点
を有している。
A conventionally known diazonium salt that can be used for this purpose is 2,5-dichlorobenzenediazonium chloride, but since it is liquid and unstable, it must be freshly prepared on the day of measuring acetoacetic acid in serum. Moreover, since the coloring product is unstable, it has the disadvantage that the measured values vary.

従って、本発明の主たる目的は結晶性粉末状ジアゾニウ
ム塩であって、冷暗所保存により数ケ月に亘って安定で
ありしかも蒸留水中に易溶であり、アセト酢酸との反応
性が高く発色生成物が安定である、p−ニトロフェニル
ジアゾニウムフルオポレートを使用する血中アゼト酵酸
の高感度簡易比色定量法を提供することである。
Therefore, the main object of the present invention is a crystalline powdery diazonium salt, which is stable for several months when stored in a cool and dark place, is easily soluble in distilled water, is highly reactive with acetoacetic acid, and does not produce colored products. An object of the present invention is to provide a simple and highly sensitive colorimetric assay method for azetoenzymatic acid in blood using stable p-nitrophenyldiazonium fluoroporate.

本発明によれば、上記目的並びに本発明を理解すること
により自から判明する他の諸目的は、a)検体血清を除
蛋白し、クエン酸緩衝液中でpニトロフェニルジアゾニ
ウムフルオポレートと反応せしめて血清中のアセト酢酸
をアゾ化合物に変じ、次いで次亜燐酸溶液を添加して残
存する上記ジアゾニウム塩を分解すると共に上記アゾ化
合物をヒドラゾ化合物に変じて溶液の吸光度(4)を3
90 nmの波長で測定する工程と、b)検体血清の代
りに6%アルブミン溶液を用いリチウムアセト酢酸の0
、0.25 、0.5 、1.0及び2.0 mM浴
溶液作成し、これを除蛋白し、次いで上記工程a)と同
様の処理を行なった後390nmの波長で吸光度を測定
し、各吸光度値から上記OmMの吸光度を(Bニブラン
ク値)を減じた値をプロットとして標準検量線を作製す
る工程とを具備しており、式 %式%) 〔式中Fは標準定量直線の吸光度が1.0のときのりチ
ウムアセト酢酸の濃度(mM/l)を意味する〕に従っ
て定量するにより遠戚される。
According to the present invention, the above objects, as well as other objects that become apparent from understanding the present invention, are: a) deproteinizing the sample serum and reacting it with p-nitrophenyldiazonium fluoroporate in a citrate buffer; to convert acetoacetic acid in the serum into an azo compound, and then add a hypophosphorous acid solution to decompose the remaining diazonium salt and convert the azo compound into a hydrazo compound, increasing the absorbance (4) of the solution to 3.
b) measuring at a wavelength of 90 nm, and b) using a 6% albumin solution instead of the sample serum to remove 0% of lithium acetoacetate.
, 0.25, 0.5, 1.0, and 2.0 mM bath solutions were prepared, protein was removed, and the absorbance was measured at a wavelength of 390 nm after performing the same treatment as in step a) above. The process includes a step of plotting the value obtained by subtracting the above OmM absorbance (B blank value) from each absorbance value to create a standard calibration curve, (formula % formula %) [In the formula, F is the absorbance of the standard quantitative straight line. is the concentration of acetoacetate (mM/l) when 1.0.

尚、本発明方法に際して生起する反応工程を示せば下記
の通りである。
The reaction steps that occur in the method of the present invention are as follows.

次に、本発明方法に使用される試薬及び本発明方法を実
施する操作等に関連して更に説明する。
Next, the reagents used in the method of the present invention and the operations for carrying out the method of the present invention will be further explained.

試薬 1、クエン酸緩衝液 0.23Mのクエン酸溶液と0.23Mのクエン酸ナト
リウム溶液とを混合してpH4,5に調整する。
Reagent 1, citric acid buffer A 0.23M citric acid solution and a 0.23M sodium citrate solution are mixed and adjusted to pH 4.5.

2、ジアゾニウム塩試薬 1)合成 p−No206H4NH,、+HNO2+HBF4→p
−NO□C6H4N2BF4+2H20p−ニトロアニ
リン3.4gを42%硼弗化水素酸11m1中に充分に
攪拌し乍ら添加し、これに氷冷亜硝酸すt−IJウム溶
液(1,7g/3.4m/?)を滴加する。
2. Diazonium salt reagent 1) Synthesis p-No206H4NH,,+HNO2+HBF4→p
-NO□C6H4N2BF4+2H20p- 3.4 g of nitroaniline was added to 11 ml of 42% borohydrofluoric acid with thorough stirring, and to this was added an ice-cold t-IJ solution of nitrite (1.7 g/3.4 ml). /?) is added dropwise.

数分間攪拌し、ガラスフィルタで吸引濾過し、氷冷硼弗
化水素酸37711で1回、95%メタノールで2回、
エチルエーテルで数回洗浄した後に五酸化燐を入れた真
空デシケータ中で乾燥せしめれば、黄色結晶状粉末であ
る所望のp−ニトロフェニルジアゾニウムフルオポレー
ト5.6g(収率95.9%)が得られる。
Stir for several minutes, filter with suction through a glass filter, once with ice-cold borohydrofluoric acid 37711, twice with 95% methanol,
After several washes with ethyl ether and drying in a vacuum desiccator with phosphorous pentoxide, 5.6 g (95.9% yield) of the desired p-nitrophenyldiazonium fluoroporate as a yellow crystalline powder was obtained. can get.

11)使用態様 1”L’mの濃度となるように蒸留水に溶解する。11) Usage mode Dissolve in distilled water to a concentration of 1"L'm.

111)保存態様 粉末体は比較的安定であり冷暗所保存により数ケ月に亘
り安定、溶液化したものは直ちに使用が原則であるが、
遮光下に水冷しておくことにより少なくとも4〜5時間
程度安定に保存しておくことができる。
111) Storage mode The powder is relatively stable and will remain stable for several months if stored in a cool and dark place.As a general rule, if it is made into a solution, it should be used immediately.
By cooling with water and shielding from light, it can be stored stably for at least 4 to 5 hours.

36 次亜燐酸溶液 20%溶液を使用 測定手技 1、除蛋白 試験管に血清0.2mlを採取し、2%過塩素酸溶液2
.0mlを混和し300 ’0.9で15分間遠心した
後の上澄液を検体溶液として使用する。
36 Measurement procedure using 20% hypophosphorous acid solution 1. Collect 0.2 ml of serum in a deproteinization test tube, and add 2% perchloric acid solution 2.
.. The supernatant after mixing 0 ml and centrifuging at 300'0.9 for 15 minutes is used as the sample solution.

2、検体溶液の発色と吸光度測定 検体溶液0.5−中にクエン酸緩衝液0.5 m1.及
びジアゾニウム塩試薬0.5mlを加えて30℃の恒温
槽内で20分間反応させる。
2. Color development and absorbance measurement of sample solution Add 0.5ml of citrate buffer to 0.5ml of sample solution. Then, 0.5 ml of diazonium salt reagent was added thereto, and the mixture was reacted for 20 minutes in a constant temperature bath at 30°C.

次いで次亜燐酸溶液0.5mlを添加して残存ジアゾニ
ウム塩を分解すると共に、生成していたアブ化合物をヒ
ドラゾ化合物に変じた後に溶液の吸光度(4)を390
nmの波長で測定する。
Next, 0.5 ml of hypophosphorous acid solution was added to decompose the remaining diazonium salt, and the generated ab compound was converted to a hydrazo compound, and the absorbance (4) of the solution was reduced to 390.
Measured at a wavelength of nm.

3、標準検量源の作製 6%アルブミン溶液を用いてリチウムアセト酢酸の0
、0.25 、0.5 、1.0及び2.0mM溶液を
調製し、これを2%過塩素酸溶液で除蛋白した後に上記
2)項と同様の操作を行ない390nmでの吸光度を測
定し、各吸光度値から上記OmMの吸光度(Bニブラン
ク値)を減じこの値をプロットして標準定量直線を作製
する。
3. Preparation of standard calibration source 0% of lithium acetoacetate using 6% albumin solution
, 0.25, 0.5, 1.0 and 2.0mM solutions were prepared, and after removing protein with a 2% perchloric acid solution, the same procedure as in 2) above was carried out and the absorbance at 390 nm was measured. Then, subtract the above OmM absorbance (B blank value) from each absorbance value and plot this value to create a standard quantitative straight line.

4、定量計算 (A−B)XF=mM/J 〔式中Fは標準定量直線の吸光度が1.0のときのりチ
ウムアセト酢酸の濃度(mM/J)を意味する〕。
4. Quantitative calculation (A-B)

測定結果 (1)第1図はアセト酢酸とジアゾニウム塩とのカップ
リング反応の最適温度について検討した結果であり、3
0℃での反応が、反応終了後の生成アゾ化合物も安定で
しかも反応終了時間も短かった。
Measurement results (1) Figure 1 shows the results of a study on the optimal temperature for the coupling reaction between acetoacetic acid and diazonium salt.
When the reaction was carried out at 0°C, the azo compound produced after the reaction was stable and the reaction completion time was short.

(2)第2図はアスト酢酸の濃度によるジアゾニウム塩
との反応時間(分)の険討結果である。
(2) Figure 2 shows the experimental results of reaction time (minutes) with diazonium salt depending on the concentration of astoacetic acid.

いずれの濃度においても20分で完全に反応は最大に達
した。
At all concentrations, the reaction completely reached its maximum level in 20 minutes.

(3)第3図はアセト酢酸の濃度による反応生成ヒドラ
ゾ化合物の吸収スペクトルを表わしたものであり、いず
れの濃度でも390 nmで吸収のピークがあった。
(3) Figure 3 shows the absorption spectrum of the hydrazo compound produced by the reaction depending on the concentration of acetoacetic acid, and there was an absorption peak at 390 nm at all concentrations.

(4)第4図はアセト酢酸の生成ヒドラゾ化合物の安定
性を示した結果であり、いずれの濃度でも経時的にほと
んど変化がなく安定であった。
(4) Figure 4 shows the stability of the hydrazo compound produced from acetoacetic acid, which was stable with almost no change over time at any concentration.

(5)第5図はアセト酢酸の標準検量線を表わしたもの
であり、明確な直線性があった。
(5) Figure 5 shows a standard calibration curve for acetoacetic acid, and there was clear linearity.

(6)第6図は血清、6%アルブミン溶液、蒸溜水のそ
れぞれにリチウムアセト酢酸を溶解して標準検量線を作
成した結果である。
(6) Figure 6 shows the results of creating a standard calibration curve by dissolving lithium acetoacetate in each of serum, 6% albumin solution, and distilled water.

いずれにおいても直線の傾きが同じであり、血清中での
りカバリ−も98%であった。
In both cases, the slope of the straight line was the same, and the coverage in serum was 98%.

【図面の簡単な説明】[Brief explanation of the drawing]

添付図面中、第1及び2図はアセト酢酸とジアゾニウム
塩とのカップリング反応と温度との及び反応時間との関
係をそれぞれ示すグラフ、第3図は生成ヒドラゾ化合物
の吸収スペクトルを示すグラフ、第4図はアセト酢酸濃
度が異なる場合の生成ヒドラゾ化合物の経時的変化を示
すグラフ、第5図はアセト酢酸標準定量直線を示すグラ
フ、第6図は蒸溜水を使用した場合と6%アリブミン溶
液を使用した場合とのアセト酢酸標準定量直線を比較し
て示すグラフである。
In the accompanying drawings, Figures 1 and 2 are graphs showing the relationship between the coupling reaction of acetoacetic acid and diazonium salt, temperature and reaction time, respectively; Figure 3 is a graph showing the absorption spectrum of the produced hydrazo compound; Figure 4 is a graph showing the change over time of the hydrazo compound produced when the acetoacetic acid concentration is different, Figure 5 is a graph showing the acetoacetic acid standard quantitative line, and Figure 6 is a graph showing the results when using distilled water and when using a 6% aribumin solution. It is a graph showing a comparison of the acetoacetic acid standard quantitative line with the case where the acetoacetic acid is used.

Claims (1)

【特許請求の範囲】 1 a)検体血清を除蛋白し、クエン酸緩衝液中でp
−ニトロフェニルジアゾニウムフルオポレートと反応せ
しめて血清中のアセト酢酸をアゾ化合物に変じ、次いで
次亜燐酸溶液を添加して残存する上記ジアゾニウム塩を
分解すると共に上記アゾ化合物をヒドラゾ化合物に変じ
て溶液の吸光度(4)390nmの波長で測定する工程
と、b)検体血清の代りに6%アルブミン溶液を用いり
チウムアセト酢酸の0 、0.25 、0.5 、1.
0及び2.0mM溶液を作製し、これを除蛋白し、次い
で上記工程a)と同様の処理を行なった後390nmの
波長で吸光度を測定し、各吸光度値から上記OmMの吸
光度(Bニブランク値)を減じた値をプロットして標準
検量線を作製する工程とを具備しており、式 %式%) 〔式中Fは標準定量直線の吸光度が1.0のときのりチ
ウムアセト酢酸の濃度(mM/lりを意味する〕に従っ
て定量することを特徴とする血中アセト酢酸の高感度簡
易比色定量法。
[Claims] 1 a) The sample serum is deproteinized and purified in a citrate buffer.
- React with nitrophenyldiazonium fluoroporate to convert acetoacetic acid in the serum into an azo compound, then add a hypophosphorous acid solution to decompose the remaining diazonium salt and convert the azo compound into a hydrazo compound to form a solution. absorbance (4) at a wavelength of 390 nm; b) measuring 0, 0.25, 0.5, 1.
Prepare 0 and 2.0mM solutions, remove protein, and then perform the same treatment as in step a) above, measure the absorbance at a wavelength of 390nm, and calculate the absorbance of OmM (B blank value) from each absorbance value. ) is plotted to create a standard calibration curve. 1. A highly sensitive and simple colorimetric method for quantifying acetoacetic acid in blood, which is characterized in that it is quantified according to [mM/l].
JP8680378A 1978-07-18 1978-07-18 Highly sensitive and simple colorimetric determination method for acetoacetic acid in blood Expired JPS5844210B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8680378A JPS5844210B2 (en) 1978-07-18 1978-07-18 Highly sensitive and simple colorimetric determination method for acetoacetic acid in blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8680378A JPS5844210B2 (en) 1978-07-18 1978-07-18 Highly sensitive and simple colorimetric determination method for acetoacetic acid in blood

Publications (2)

Publication Number Publication Date
JPS5515004A JPS5515004A (en) 1980-02-01
JPS5844210B2 true JPS5844210B2 (en) 1983-10-01

Family

ID=13896949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8680378A Expired JPS5844210B2 (en) 1978-07-18 1978-07-18 Highly sensitive and simple colorimetric determination method for acetoacetic acid in blood

Country Status (1)

Country Link
JP (1) JPS5844210B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6452905U (en) * 1987-09-30 1989-03-31

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2804267B2 (en) * 1988-05-02 1998-09-24 オリンパス光学工業株式会社 Endoscope objective lens
US6618205B2 (en) 2001-05-14 2003-09-09 Pentax Corporation Endoscope objective optical system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6452905U (en) * 1987-09-30 1989-03-31

Also Published As

Publication number Publication date
JPS5515004A (en) 1980-02-01

Similar Documents

Publication Publication Date Title
Morse Anthrone in estimating low concentrations of sucrose
Trinder A rapid method for the determination of sodium in serum
Goodwin Quantification of serum inorganic phosphorus, phosphatase, and urinary phosphate without preliminary treatment
JPS60249037A (en) Measuring device for substance to be analyzed and method of checking said device
US3652222A (en) Bilirubin assay
Nogare et al. Determination of Acetaldehyde and Acetone by Iodoform Reaction
JPS5844210B2 (en) Highly sensitive and simple colorimetric determination method for acetoacetic acid in blood
Loomis Rapid microcolorimetric determination of dissolved oxygen
US3528777A (en) Process and compositions for determination of uric acid in blood serum
CN105842437A (en) Kit for detecting D-3-hydroxybutyric acid and preparation method of kit
EP0510190A1 (en) Reagent and method for serum iron assay.
JPS61223651A (en) Method for quantitative determination of bilirubin
Carr Reactions of aromatic nitro compounds with active methyl, methylene, methine groups in presence of base
Asp Improved method for the assay of phenylglycosidase activity with a 4-aminoantipyrine reagent
JP2008501121A (en) Assay system using in situ formation of diazo reagent
Davidson 34—the determination of methylene blue
Schlebusch et al. Comparison of five routine methods with the candidate reference method for the determination of bilirubin in neonatal serum
Terasaki et al. Automated method for the quantitation of orthophosphate
JPS5844211B2 (en) Highly sensitive and simple colorimetric determination method for blood ketone bodies
KR100295183B1 (en) Method for measuring the effective amount of phosphoric acid of solution leached by lancaster method
Kaselis et al. Modified colorimetric assay of pteroylglutamic acid
SU821404A1 (en) Method of determining concentration of oxygen dissolved in water
Zak et al. Spectrophotometric study of some oxidative products of bilirubin
JPS6342470A (en) Method for measuring peroxidase or h2o2
Belcher et al. The determination of small amounts of hydroquinone